Attovia is headquartered at 1091 Industrial Road, Suite 310, San Carlos, California 94070
Attovia Therapeutics is incorporated in the state of Delaware
Attovia was founded and commenced operations in 2023
Attovia commenced trading on the NASDAQ stock exchange on August 5, 2026
Attovia’s fiscal year ends on December 31st
Attovia is traded on the NASDAQ stock exchange under the ticker symbol “ATTO”, and its CUSIP number is 04987L 102
Fidelity Stock Transfer℠ (FST)
You may contact Fidelity Stock Transfer℠ (FST) with any questions about your share ownership through any of the methods listed here:
Phone: (Toll-Free) (833) 500-1036
Representatives are available to assist you by phone from 8:00 AM to 8:00 PM EST, Monday through Friday
Website
If you have an existing account accessed through Fidelity.com or NetBenefits.com, you can log in to view your account holdings by navigating to the Registered Stock section
Email
FSTOperations@fmr.com
Mail
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
PO Box 770017
Cincinnati, OH 45277
Overnight Mail
Fidelity Investments
Attn: Fidelity Stock Transfer Solutions
100 Crosby Parkway
Mail Zone KY16
Covington, KY 41015
PricewaterhouseCoopers LLP
Fenwick & West LLP
Attovia’s press release archives can be viewed here
- Attovia’s SEC filings can be viewed here
- Additionally, all SEC filings can be accessed directly from the SEC at www.sec.gov
You can submit inquiries to Attovia’s investor relations by contacting ir@attovia.com
